A new era for psilocybin and psilocin.
Driven by patient outcomes.
for patients
Life-changing potential for millions of patients.
Nearly 100,000
people in the United States have been diagnosed with complex regional pain syndrome (CRPS).
60%+
of patients who have lost a limb experience phantom limb pain.
Nearly 30%
of fibromyalgia patients use opioids to address pain symptoms despite risks of addiction and overdose.
Nearly 30%
of individuals looking for weight loss treatments show signs of binge eating disorder.
<10,000
diagnosed cases of hypothalamic obesity in the US, with no approved treatment options.
Only 10%
of fibromyalgia patients continue to use currently available treatments due to side effects and lack of efficacy.
2%
of males are affected by binge eating disorder at some point in their lives.
1 million+
people in the United States are affected by phantom limb pain.
3.5%
of females are affected by binge eating disorder at some point in their lives.
Significant opportunities for investors.
